Patents by Inventor Simon David Betson

Simon David Betson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE
    Publication number: 20250213537
    Abstract: Disclosed herein are compositions and methods for topical delivery of mTOR inhibitors. In one embodiment, an anhydrous composition includes one or more mTOR inhibitors, one or more solvents, one or more gelling agents, and one or more antioxidants. Also disclosed herein are methods to treat skin disorders using such compositions.
    Type: Application
    Filed: March 19, 2025
    Publication date: July 3, 2025
    Applicant: PALVELLA THERAPEUTICS, INC.
    Inventors: Wesley Harton KAUPINEN, Braham SHROOT, Simon David BETSON, Charles Rodney GREENAWAY EVANS, Marc Barry BROWN
  • Anhydrous compositions of mTOR inhibitors and methods of use
    Patent number: 12329748
    Abstract: Disclosed herein are compositions and methods for topical delivery of mTOR inhibitors. In one embodiment, an anhydrous composition includes one or more mTOR inhibitors, one or more solvents, one or more gelling agents, and one or more antioxidants. Also disclosed herein are methods to treat skin disorders using such compositions.
    Type: Grant
    Filed: May 1, 2023
    Date of Patent: June 17, 2025
    Assignee: PALVELLA THERAPEUTICS, INC.
    Inventors: Wesley Harton Kaupinen, Braham Shroot, Simon David Betson, Charles Rodney Greenaway Evans, Marc Barry Brown
  • Anhydrous compositions of mTOR inhibitors and methods of use
    Patent number: 12268673
    Abstract: Disclosed herein are compositions and methods for topical delivery of mTOR inhibitors. In one embodiment, an anhydrous composition includes one or more mTOR inhibitors, one or more solvents, one or more gelling agents, and one or more antioxidants. Also disclosed herein are methods to treat skin disorders using such compositions.
    Type: Grant
    Filed: August 31, 2021
    Date of Patent: April 8, 2025
    Assignee: PALVELLA THERAPEUTICS, INC.
    Inventors: Wesley Harton Kaupinen, Braham Shroot, Simon David Betson, Charles Rodney Greenaway Evans, Marc Barry Brown
  • ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE
    Publication number: 20240398766
    Abstract: Disclosed herein are compositions and methods for topical delivery of mTOR inhibitors. In one embodiment, an anhydrous composition includes one or more mTOR inhibitors, one or more solvents, one or more gelling agents, and one or more antioxidants. Also disclosed herein are methods to treat skin disorders using such compositions.
    Type: Application
    Filed: August 15, 2024
    Publication date: December 5, 2024
    Applicant: PALVELLA THERAPEUTICS, INC.
    Inventors: Wesley Harton KAUPINEN, Braham SHROOT, Simon David BETSON, Charles Rodney GREENAWAY EVANS, Marc Barry BROWN
  • ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE
    Publication number: 20230263781
    Abstract: Disclosed herein are compositions and methods for topical delivery of mTOR inhibitors. In one embodiment, an anhydrous composition includes one or more mTOR inhibitors, one or more solvents, one or more gelling agents, and one or more antioxidants. Also disclosed herein are methods to treat skin disorders using such compositions.
    Type: Application
    Filed: May 1, 2023
    Publication date: August 24, 2023
    Applicant: PALVELLA THERAPEUTICS, INC.
    Inventors: Wesley Harton KAUPINEN, Braham SHROOT, Simon David BETSON, Charles Rodney GREENAWAY EVANS, Marc Barry BROWN
  • Anhydrous compositions of mTOR inhibitors and methods of use
    Patent number: 11679101
    Abstract: Disclosed herein are compositions and methods for topical delivery of mTOR inhibitors. In one embodiment, an anhydrous composition includes one or more mTOR inhibitors, one or more solvents, one or more gelling agents, and one or more antioxidants. Also disclosed herein are methods to treat skin disorders using such compositions.
    Type: Grant
    Filed: April 7, 2021
    Date of Patent: June 20, 2023
    Assignee: PALVELLA THERAPEUTICS, INC.
    Inventors: Wesley Harton Kaupinen, Braham Shroot, Simon David Betson, Charles Rodney Greenaway Evans, Marc Barry Brown
  • ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE
    Publication number: 20220016089
    Abstract: Disclosed herein are compositions and methods for topical delivery of mTOR inhibitors. In one embodiment, an anhydrous composition includes one or more mTOR inhibitors, one or more solvents, one or more gelling agents, and one or more antioxidants. Also disclosed herein are methods to treat skin disorders using such compositions.
    Type: Application
    Filed: August 31, 2021
    Publication date: January 20, 2022
    Applicant: PALVELLA THERAPEUTICS, INC.
    Inventors: Wesley Harton KAUPINEN, Braham SHROOT, Simon David BETSON, Charles Rodney GREENAWAY EVANS, Marc Barry BROWN
  • Anhydrous compositions of mTOR inhibitors and methods of use
    Patent number: 11135204
    Abstract: Disclosed herein are compositions and methods for topical delivery of mTOR inhibitors. In one embodiment, an anhydrous composition includes one or more mTOR inhibitors, one or more solvents, one or more gelling agents, and one or more antioxidants. Also disclosed herein are methods to treat skin disorders using such compositions.
    Type: Grant
    Filed: June 18, 2020
    Date of Patent: October 5, 2021
    Assignee: Palvella Therapeutics, Inc.
    Inventors: Wesley Harton Kaupinen, Braham Shroot, Simon David Betson, Charles Rodney Greenaway Evans, Marc Barry Brown
  • ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE
    Publication number: 20210244713
    Abstract: Disclosed herein are compositions and methods for topical delivery of mTOR inhibitors. In one embodiment, an anhydrous composition includes one or more mTOR inhibitors, one or more solvents, one or more gelling agents, and one or more antioxidants. Also disclosed herein are methods to treat skin disorders using such compositions.
    Type: Application
    Filed: April 7, 2021
    Publication date: August 12, 2021
    Applicant: PALVELLA THERAPEUTICS, INC.
    Inventors: Wesley Harton KAUPINEN, Braham SHROOT, Simon David BETSON, Charles Rodney GREENAWAY EVANS, Marc Barry BROWN
  • Anhydrous compositions of mTOR inhibitors and methods of use
    Patent number: 11000513
    Abstract: Disclosed herein are compositions and methods for topical delivery of mTOR inhibitors. In one embodiment, an anhydrous composition includes one or more mTOR inhibitors, one or more solvents, one or more gelling agents, and one or more antioxidants. Also disclosed herein are methods to treat skin disorders using such compositions.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: May 11, 2021
    Assignee: Palvella Therapeutics, Inc.
    Inventors: Wesley Harton Kaupinen, Braham Shroot, Simon David Betson, Charles Rodney Greenaway Evans, Marc Barry Brown
  • ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE
    Publication number: 20200316034
    Abstract: Disclosed herein are compositions and methods for topical delivery of mTOR inhibitors. In one embodiment, an anhydrous composition includes one or more mTOR inhibitors, one or more solvents, one or more gelling agents, and one or more antioxidants. Also disclosed herein are methods to treat skin disorders using such compositions.
    Type: Application
    Filed: June 18, 2020
    Publication date: October 8, 2020
    Applicant: PALVELLA THERAPEUTICS, INC.
    Inventors: Wesley Harton KAUPINEN, Braham SHROOT, Simon David BETSON, Charles Rodney GREENAWAY EVANS, Marc Barry BROWN
  • Anyhydrous compositions of mTOR inhibitors and methods of use
    Patent number: 10722499
    Abstract: Disclosed herein are compositions and methods for topical delivery of mTOR inhibitors. In one embodiment, an anhydrous composition includes one or more mTOR inhibitors, one or more solvents, one or more gelling agents, and one or more antioxidants. Also disclosed herein are methods to treat skin disorders using such compositions.
    Type: Grant
    Filed: January 5, 2018
    Date of Patent: July 28, 2020
    Assignee: PALVELLA THERAPEUTICS, INC.
    Inventors: Wesley Harton Kaupinen, Braham Shroot, Simon David Betson, Charles Rodney Greenaway Evans, Marc Barry Brown